156 related articles for article (PubMed ID: 12861359)
1. Leflunomide: efficacy and safety in clinical trials for the treatment of rheumatoid arthritis.
Schiff MH; Strand V; Oed C; Loew-Friedrich I
Drugs Today (Barc); 2000 Jun; 36(6):383-94. PubMed ID: 12861359
[TBL] [Abstract][Full Text] [Related]
2. The use of leflunomide in the treatment of rheumatoid arthritis: an experimental and clinical review.
Schattenkirchner M
Immunopharmacology; 2000 May; 47(2-3):291-8. PubMed ID: 10878295
[TBL] [Abstract][Full Text] [Related]
3. Leflunomide, a novel immunomodulator for the treatment of active rheumatoid arthritis.
Goldenberg MM
Clin Ther; 1999 Nov; 21(11):1837-52; discussion 1821. PubMed ID: 10890256
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of leflunomide in active rheumatoid arthritis.
Smolen JS; Emery P
Rheumatology (Oxford); 2000 Jun; 39 Suppl 1():48-56. PubMed ID: 11001380
[TBL] [Abstract][Full Text] [Related]
5. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group.
Strand V; Cohen S; Schiff M; Weaver A; Fleischmann R; Cannon G; Fox R; Moreland L; Olsen N; Furst D; Caldwell J; Kaine J; Sharp J; Hurley F; Loew-Friedrich I
Arch Intern Med; 1999 Nov; 159(21):2542-50. PubMed ID: 10573044
[TBL] [Abstract][Full Text] [Related]
6. Leflunomide in the treatment of rheumatoid arthritis.
Li EK; Tam LS; Tomlinson B
Clin Ther; 2004 Apr; 26(4):447-59. PubMed ID: 15189743
[TBL] [Abstract][Full Text] [Related]
7. Leflunomide: a novel DMARD for the treatment of rheumatoid arthritis.
Alldred A; Emery P
Expert Opin Pharmacother; 2001 Jan; 2(1):125-37. PubMed ID: 11336574
[TBL] [Abstract][Full Text] [Related]
8. Leflunomide: a review of its use in active rheumatoid arthritis.
Prakash A; Jarvis B
Drugs; 1999 Dec; 58(6):1137-64. PubMed ID: 10651393
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of leflunomide].
Hirohata S
Nihon Rinsho; 2002 Dec; 60(12):2357-63. PubMed ID: 12510362
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with leflunomide in rheumatoid arthritis. Leflunomide Investigators' Group.
Rozman B
J Rheumatol Suppl; 1998 Jul; 53():27-32. PubMed ID: 9666415
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action for leflunomide in rheumatoid arthritis.
Fox RI; Herrmann ML; Frangou CG; Wahl GM; Morris RE; Strand V; Kirschbaum BJ
Clin Immunol; 1999 Dec; 93(3):198-208. PubMed ID: 10600330
[TBL] [Abstract][Full Text] [Related]
12. Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial.
Wijesinghe H; Galappatthy P; de Silva R; Seneviratne SL; Saravanamuttu U; Udagama P; Hart M; Kelleher P; Senerath U; Fernandopulle R; Weerasekera LP; Wijayaratne LS
BMC Musculoskelet Disord; 2017 Jul; 18(1):310. PubMed ID: 28724365
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate and leflunomide: biochemical basis for combination therapy in the treatment of rheumatoid arthritis.
Kremer JM
Semin Arthritis Rheum; 1999 Aug; 29(1):14-26. PubMed ID: 10468411
[TBL] [Abstract][Full Text] [Related]
14. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
15. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis.
Emery P; Breedveld FC; Lemmel EM; Kaltwasser JP; Dawes PT; Gömör B; Van Den Bosch F; Nordström D; Bjorneboe O; Dahl R; Horslev-Petersen K; Rodriguez De La Serna A; Molloy M; Tikly M; Oed C; Rosenburg R; Loew-Friedrich I
Rheumatology (Oxford); 2000 Jun; 39(6):655-65. PubMed ID: 10888712
[TBL] [Abstract][Full Text] [Related]
17. Disease modification in rheumatoid arthritis with leflunomide.
Emery P
Scand J Rheumatol Suppl; 1999; 112():9-14. PubMed ID: 10668522
[TBL] [Abstract][Full Text] [Related]
18. Leflunomide for the treatment of rheumatoid arthritis and autoimmunity.
Sanders S; Harisdangkul V
Am J Med Sci; 2002 Apr; 323(4):190-3. PubMed ID: 12003373
[TBL] [Abstract][Full Text] [Related]
19. How does leflunomide modulate the immune response in rheumatoid arthritis?
Fox RI; Herrmann ML; Frangou CG; Wahl GM; Morris RE; Kirschbaum BJ
BioDrugs; 1999 Oct; 12(4):301-15. PubMed ID: 18031184
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.
Smolen JS; Kalden JR; Scott DL; Rozman B; Kvien TK; Larsen A; Loew-Friedrich I; Oed C; Rosenburg R
Lancet; 1999 Jan; 353(9149):259-66. PubMed ID: 9929017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
